Rottenstein Law Group Encouraged by FDA’s Proposal to Move Up Deadline for Complying with Unique Medical Device Identification Rules

The Rottenstein Law Group, which represents clients with claims stemming from harms caused by defective medical devices, has learned that the FDA has proposed an accelerated timeline for establishing a unique device identification (UDI) system for certain medical devices. (Prior results do not guarantee a similar outcome.)

 

New York (PRWEB) December 03, 2012

 

To improve the management of medical device recalls and systems for identifying and correcting potentially dangerous problems with medical devices, in June 2012 the FDA proposed implementing an identification system that would assign to nearly every medical device on the U.S. market a unique code that will be the key to certain basic identifying information about the device. Now, the agency has amended the proposal to require that “implantable, life-supporting and life-sustaining” devices bear the unique identifier codes—known as UDIs—sooner than the FDA had originally proposed, reports the website for the Association for the Advancement of Medical Instrumentation (AAMI). The new proposal moves up the deadline by which implantable devices must bear UDIs by one to five years, depending on whether the device falls into the high-, moderate-, or low-risk category, according to the AAMI website.

 

The Rottenstein Law Group’s principal, Rochelle Rottenstein, is the devoted advocate of claimants allegedly injured by recalled medical devices—including Boston Scientific's Protegen Sling vaginal mesh product, which was recalled in 1999, according to a May 4, 2009, New York Times article. As a representative of women who have filed vaginal mesh lawsuits, Rottenstein is aware of the importance of keeping track of adverse event reports filed in connection with injuries sustained from medical devices. Accordingly, Rottenstein has long been a proponent of the FDA's adoption of a UDI system, which she believes can go a long way toward minimizing the injuries caused by potentially dangerous medical devices.

 

Read full story on PRWeb.com – Rottenstein Law Group Encouraged by FDA’s Proposal to Move Up Deadline for Complying with Unique Medical Device Identification Rules